1. Executive Summary 2. United States Influenza Vaccines Market Size & Analysis (2013 - 2025) 3. United States Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025) 3.1 Number of Children Vaccinated with Influenza Vaccines 3.2 Number of Adults Vaccinated with Influenza Vaccines 4. Key Drivers and Inhibitors of the United States Influenza Vaccines Market 4.1 Market Drivers 4.2 Market Restraints 5. United States Influenza Vaccines Pricing Trends & Analysis 6. United States Influenza Vaccines Production, Supply, and Allocation (By Companies) 7. United States Influenza Vaccines Distribution & Demand (2010 - 2019) 8. Effectiveness of Influenza Vaccines in the United States (2004 – 2019) 9. Rapid Diagnostic Testing for the Management of Influenza 10. Distribution Channel & Technique of Influenza Vaccination in United States 11. United States Influenza Vaccines Reimbursement Policies & Regulatory System 11.1 Reimbursement Policies 11.2 Regulation System 12. Major Deals in the Influenza Vaccines Market 12.1 Merger & Acquisitions 12.2 Collaboration Deal 12.3 Licensing Agreement 12.4 Exclusive Agreement 12.5 Distribution Agreement 13. Promising Influenza Vaccines in the Clinical Development 14. Influenza Vaccines Clinical Trial Insights by Phase, Company & Country 14.1 Year 2018 14.2 Year 2017 15. Key Companies Analysis 15.1 Sanofi Pasteur 15.1.1 Business Overview 15.1.2 Influenza Vaccines Portfolio 15.1.3 Influenza Vaccines Sales Value Analysis 15.1.4 Recent Development 15.2 GlaxoSmithKline (GSK) 15.2.1 Business Overview 15.2.2 Influenza Vaccines Portfolio 15.2.3 Influenza Vaccines Sales Value Analysis 15.2.4 Recent Development 15.3 Seqirus 15.3.1 Business Overview 15.3.2 Influenza Vaccines Portfolios 15.3.3 Recent Development 15.4 AstraZeneca 15.4.1 Business Overview 15.4.2 Influenza Vaccines Portfolio 15.4.3 Influenza Vaccines Sales Value Analysis 15.4.4 Recent Development

List of Tables: Table 5–1: United States Pediatric Influenza Vaccines Price, 2019 – 2020 Table 5–2: United States Adult Influenza Vaccine Price, 2019 – 2020 Table 6–1: United States Influenza Vaccines Production, Supply, and Allocation Table 7–1: Total Percentage of Influenza Vaccines Released by Week,2018 – 2019 Table 7–2: Total Percentage of Influenza Vaccines Released by Week,2017 – 2018 Table 7–3: Total Percentage of Influenza Vaccines Released by Week,2016 – 2017 Table 7–4: Total Percentage of Influenza Vaccines Released by Week,2015 – 2016 Table 7–5: Total Percentage of Influenza Vaccines Released by Week,2014 – 2015 Table 8–1: Adjusted Vaccine Effectiveness Estimates for Influenza Seasons, 2004 – 2019 Table 9–1: Influenza Virus Testing Methods Table 10–1: Distribution of Influenza Vaccination Table 11–1: United States Simplified Regulatory Pathway from Preclinical to the Marketing Authorization Table 12–1: Merger & Acquisitions in the Influenza Vaccines Market Table 12–2: Collaboration Deal in the Influenza Vaccines Market Table 12–3: Licensing Agreement in the Influenza Vaccines Market Table 12–4: Exclusive Agreement in the Influenza Vaccines Market Table 12–5: Distribution Agreement in the Influenza Vaccines Market List of Figures: Figure 2–1: United States Influenza Vaccines Market (Million US$),2013 – 2018 Figure 2–2: United States Influenza Vaccines Market Forecast (Million US$),2019 – 2025 Figure 3–1: United States Total Number of Persons Vaccinated with Influenza Vaccines (Thousand),2013 – 2018 Figure 3–2: United States Total Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025 Figure 3–3: United States Number of Children Vaccinated with Influenza Vaccines (Thousand),2013 – 2018 Figure 3–4: United States Number of Children Vaccinated with Influenza Vaccines Forecast (Thousand),2019 – 2025 Figure 3–5: United States Number of Adults Vaccinated with Influenza Vaccines (Thousand),2013 – 2018 Figure 3–6: United States Number of Adults Vaccinated with Influenza Vaccines Forecast (Thousand),2019 – 2025 Figure 7–1: United States Influenza Vaccine Doses Distributed, By Season (Million),2010 – 2019 Figure 10–1: United States Place of Influenza Vaccination for Children and Adults (Percent),2018 - 2019 Figure 15–1: Sanofi Pasteur Influenza Vaccines Net Sales Value (Million US$),2013 – 2018 Figure 15–2: Sanofi Pasteur Influenza Vaccines Net Sales Value Forecast (Million US$),2019 – 2025 Figure 15–3: GSK Influenza Vaccines Net Sales Value (Million US$),2013 – 2018 Figure 15–4: GSK Influenza Vaccines Net Sales Value Forecast (Million US$),2019 – 2025 Figure 15–5: AstraZeneca Influenza Vaccines Net Sales Value (Million US$),2013 – 2018 Figure 15–6: AstraZeneca Influenza Vaccines Net Sales Value Forecast (Million US$),2019 – 2025